CorMedix
CRMD
#6892
Rank
A$0.87 B
Marketcap
A$11.14
Share price
-3.24%
Change (1 day)
-33.33%
Change (1 year)

Earnings for CorMedix (CRMD)

Earnings in 2025 (TTM): A$0.16 Billion

According to CorMedix's latest financial reports the company's current earnings are A$0.21 Billion. In 2024 the company made an earning of -A$27.76 Million, an increase over its 2023 earnings that were of -A$66.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CorMedix from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.16 B-695.26%
2024 -A$27.76 Million-58.3%
2023 -A$66.55 Million53%
2022 -A$43.5 Million2.81%
2021 -A$42.31 Million8.32%
2020 -A$39.06 Million26.53%
2019 -A$30.87 Million-19.89%
2018 -A$38.53 Million-18.72%
2017 -A$47.41 Million34.56%
2016 -A$35.23 Million34.88%
2015 -A$26.12 Million-11.08%
2014 -A$29.38 Million124.69%
2013 -A$13.08 Million144.91%
2012 -A$5.34 Million-48.41%
2011 -A$10.35 Million-33.29%
2010 -A$15.51 Million78.42%
2009 -A$8.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Becton Dickinson
BDX
A$2.70 B 1,658.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$20.99 M-86.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B 54.44%๐Ÿ‡บ๐Ÿ‡ธ USA